Curavit was founded by industry veterans to revolutionize the way clinical research
is conducted,

Curavit’s founders, each with three decades of experience at the intersection of technology and clinical research, had a vision to disrupt traditional clinical trials in a way that would better serve patients and the industry by designing and executing decentralized (or virtual) clinical trials.

 

Leadership Team

Joel Morse

Chief Executive Officer

Joel Morse is Founder and CEO of Curavit. He is an experienced operational CEO who has founded, built, and sold large global businesses in healthcare and life sciences. Previously, he founded C3i, a Business Process Outsourcing (BPO) healthcare provider, and built it into a global leader in tech-enabled clinical trial services, with a strategic client list that included Medidata, Quintiles, and Merck. Joel has a BS in mechanical engineering from Tufts, and an MBA from Columbia.

Pam Diamond, MD

Chief Medical Officer

Dr. Pam Diamond is Co-founder and Chief Medical Officer of Curavit. She is a Board Certified, Boston-based Otolaryngologist/Head and Neck Surgeon who was affiliated with Harvard Medical School (HMS) and Massachusetts Eye and Ear Infirmary (MEEI) for over 30 years.  At Curavit, Dr. Diamond provides medical and scientific expertise and oversight to the design and execution of Curavit’s decentralized clinical trials. She received her medical degree from the University of Rochester School of Medicine and completed her Otolaryngology/Head and Neck Surgery residency at Harvard Medical School/MEEI.

Dave Hanaman

President & Chief Commercial Officer

Dave Hanaman is Co-founder, President and Chief Commercial Officer of Curavit.  He is a proven entrepreneur, operator, and board director with successful, strategic exits to public companies. Founder of C3i, a Business Process Outsourcing (BPO) healthcare provider, Dave developed and led its sales, marketing, product development, and alliance strategies. Dave serves as a board member and advisor to several start-up and growth-stage companies in healthcare and technology. He graduated from the University of California at Berkeley and served as a deployed U.S. Navy intelligence officer.

Jay Collier

Chief Operating Officer

Jay Collier is  Chief Operating Officer (COO) of Curavit. Jay is responsible for managing all aspects of service delivery for Curavit’s clients. Jay has over 20 years of operational experience serving global clients in life sciences and clinical research. Jay has a BA from the University of Massachusetts Amherst.

Is your research a fit for a decentralized clinical trial?

Find out more about what trial are – and aren’t – well suited for decentralized processes and technologies.  Curavit’s team can help you understand the challenges, and benefits.  Please contact us to learn more.